Jpmorgan Chase & CO Milestone Scientific Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Milestone Scientific Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 374 shares of MLSS stock, worth $344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374
Previous 358
4.47%
Holding current value
$344
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MLSS
# of Institutions
37Shares Held
4.29MCall Options Held
5.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA2.15MShares$1.97 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA495KShares$455,7980.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX402KShares$369,5640.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2252KShares$231,6860.15% of portfolio
-
Carnegie Capital Asset Management, LLC145KShares$133,5810.0% of portfolio
About MILESTONE SCIENTIFIC INC.
- Ticker MLSS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 68,920,896
- Market Cap $63.4M
- Description
- Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that...